Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cathay Biotech is a leading global synthetic biology company specializing in the research, development, and commercial production of bio-based materials. The company utilizes proprietary microbial fermentation and purification technologies to produce long-chain dicarboxylic acids, bio-based diamines, and bio-based polyamides. Their products serve a wide range of industries, including textiles, automotive, electronics, and healthcare, where they provide sustainable alternatives to petroleum-based chemicals. Cathay Biotech is recognized for its large-scale industrialization of synthetic biology processes, maintaining a dominant market share in the global bio-based long-chain dicarboxylic acid market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Anthracite Kaisai Biotechnology.